Toxicokinetic, toxicodynamic, and toxicoproteomic aspects of short-term exposure to trenbolone in female fish.
The toxicokinetics of trenbolone was characterized during 500 ng/l water exposures in female rainbow trout (Oncorhynchus mykiss) and fathead minnows (Pimephales promelas). Related experiments measured various toxicodynamic effects of exposure. In both species, trenbolone was rapidly absorbed from the water and reached peak plasma levels within 8h of exposure. Afterwards, trenbolone concentrations in trout (66-95 ng/ml) were 2-6 times higher compared with minnows (15-29 ng/ml), which was attributable to greater plasma binding in trout. During water exposures, circulating levels of estradiol (E2) rapidly decreased in both species to a concentration that was 25%-40% of control values by 8-24h of exposure and then remained relatively unchanged for the subsequent 6 days of exposure. In trout, changes in circulating levels of follicle-stimulating hormone were also significantly greater after trenbolone exposure, relative to controls. In both species, the pharmacokinetics of injected E2-d3 was altered by trenbolone exposure with an increase in total body clearance and a corresponding decrease in elimination half-life. The unbound percentage of E2 in trout plasma was 0.25%, which was similar in pre- or postvitellogenic female trout. Subsequent incubation with trenbolone caused the unbound percentage to significantly increase to 2.4% in the previtellogenic trout plasma. iTRAQ-based toxicoproteomic studies in minnows exposed to 5, 50, and 500 ng/l trenbolone identified a total of 148 proteins with 19 downregulated including vitellogenin and 18 upregulated. Other downregulated proteins were fibrinogens, α-2-macroglobulin, and transferrin. Upregulated proteins included amine oxidase, apolipoproteins, parvalbumin, complement system proteins, and several uncharacterized proteins. The results indicate trenbolone exposure is a highly dynamic process in female fish with uptake and tissue equilibrium quickly established, leading to both rapid and delayed toxicodynamic effects.
* Battelle, Pacific Northwest National Laboratory, Marine Sciences Laboratory, Sequim, Washington 98382;
Irvin R
IR
Schultz
James J
JJ
Nagler
Penny
P
Swanson
Dave
D
Wunschel
Ann D
AD
Skillman
Vicki
V
Burnett
Derek
D
Smith
Richard
R
Barry
D045930:Anabolic Agents / Q000493:pharmacokinetics / Q000633:toxicity*; D000818:Animals; D002853:Chromatography, Liquid; D003530:Cyprinidae; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D017686:Oncorhynchus mykiss; D040901:Proteomics; D021241:Spectrometry, Mass, Electrospray Ionization; D053719:Tandem Mass Spectrometry; D014204:Trenbolone Acetate / Q000493:pharmacokinetics / Q000633:toxicity*
D045930:Anabolic Agents; D014204:Trenbolone Acetate
androgenic; clearance; gonadotropin; iTRAQ; plasma binding.